Chemicalstructure (Chemical Structure)
Tizanidine Hydrochloride
Product Images NDC 42291-810
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Tizanidine Hydrochloride (NDC 42291-810). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Avkare, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure2 (Figure 2)
Figure3 (Figure 3)
The text refers to a study that shows the improvement in Ashworth Score after the use of Tizanidine with a mean dose of 26.8 mg. The study includes observations at the end of titration, end of maintenance, and endpoint.*
Figure1 (Figure1)
This seems to be a table with two columns labeled "T2" and "14 16 18". The row under the columns is labeled "Hours from Dosing" and the number "0" is displayed in the table. Without any additional context, it is not possible to provide a useful description for this text.*
Label 4229181015 Tizanidine Hci 2016 2mg
Label 4229181115 Tizanidine Hci 2018 4mg
"RxOnly Capsules 150 Capsules Tizanid Hydrochloride".*
Label 4229181215 Tizanidine 2019 6mg
The text appears to be a prescription drug label for AVKARE Tizanidine Hydrochloride Capsules, with a National Drug Code (NDC) of 42291-812-15. Each capsule contains 6 mg of the active ingredient. The label states that there are 150 capsules and that it is for prescription use only.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
